English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing

MPS-Authors
/persons/resource/persons210762

Schreiber,  F.
Department of Biogeochemistry, Max Planck Institute for Marine Microbiology, Max Planck Society;

/persons/resource/persons210257

deBeer,  D.
Permanent Research Group Microsensor, Max Planck Institute for Marine Microbiology, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)

Schreiber10.pdf
(Publisher version), 531KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Barak, Y., Schreiber, F., Thorne, S. H., Contag, C. H., deBeer, D., & Matin, A. (2010). Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing. BMC Cancer, 10, 146-152.


Cite as: http://hdl.handle.net/21.11116/0000-0001-CB38-C
Abstract
Background: Bacterial targeting of tumours is an important anti-cancer strategy. We previously showed that strain SL7838 of Salmonella typhimurium targets and kills cancer cells. Whether NO generation by the bacteria has a role in SL7838 lethality to cancer cells is explored. This bacterium has the mechanism for generating NO, but also for decomposing it. Methods: Mechanism underlying Salmonella typhimurium tumour therapy was investigated through in vitro and in vivo studies. NO measurements were conducted either by chemical assays (in vitro) or using Biosensors (in vivo). Cancer cells cytotoxic assay were done by using MTS. Bacterial cell survival and tumour burden were determined using molecular imaging techniques. Results: SL7838 generated nitric oxide (NO) in anaerobic cell suspensions, inside infected cancer cells in vitro and in implanted 4T1 tumours in live mice, the last, as measured using microsensors. Thus, under these conditions, the NO generating pathway is more active than the decomposition pathway. The latter was eliminated, in strain SL7842, by the deletion of hmp- and norV genes, making SL7842 more proficient at generating NO than SL7838. SL7842 killed cancer cells more effectively than SL7838 in vitro, and this was dependent on nitrate availability. This strain was also ca. 100% more effective in treating implanted 4T1 mouse tumours than SL7838.